Davis Polk advised AstraZeneca on the offering, while Simpson Thacher represented the underwriters. AstraZeneca PLC executed its SEC-registered shelf takedown of $1.2 billion aggregate principal amount of…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
